Myeloablative chemoradiotherapy versus continued chemotherapy for high risk neuroblastoma.
University of Southern California School of Medicine, Los Angeles 90033.
D O
DO
Stram
K K
KK
Matthay
M
M
O'Leary
C P
CP
Reynolds
R C
RC
Seeger
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D006801:Humans; D007223:Infant; D009447:Neuroblastoma / Q000188:drug therapy* / Q000532:radiotherapy* / Q000628:therapy; D011379:Prognosis; D012307:Risk Factors; D016019:Survival Analysis